Keywords: خطر ابتلا به بدخیمی; Frozen section analysis; Ovarian tumors; Risk of malignancy index;
مقالات ISI خطر ابتلا به بدخیمی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خطر ابتلا به بدخیمی; Risk of Malignancy Index; Primary evaluation; Ovarian masses
Keywords: خطر ابتلا به بدخیمی; adnexal lesion; parity; risk of malignancy index
Keywords: خطر ابتلا به بدخیمی; adnexal mass; CA-125; ovarian cancer; risk of malignancy index; Wales
Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
Keywords: خطر ابتلا به بدخیمی; Ovarian cancer; Diagnostic/prognostic biomarkers; MicroRNA; Epigenetics; Next Generation Sequencing; OC; Ovarian cancer; FIGO; International Federation of Gynecology and Obstetrics; CA125; Cancer Antigen 125; RMI; Risk of Malignancy Index; DGCD; Danish Gy
Human epididymis protein 4 (HE4) in laboratory medicine and an algorithm in renal disorders
Keywords: خطر ابتلا به بدخیمی; HE4; Human epididymis protein 4; CA125; Cancer antigen 125; TVU; Transvaginal ultrasound; EOC; Epithelial ovarian cancer; CMIA; Chemiluminescent microparticle immunoassay; RMI; Risk of malignancy index; ROMA; Risk of ovarian malignancy; SMRP; Soluble meso
Risk of malignancy index validity assessment in premenopausal and postmenopausal women with adnexal tumors
Keywords: خطر ابتلا به بدخیمی; adnexal masses; postmenopause; premenopause; risk of malignancy index
Combination of Serum Biomarkers to Differentiate Malignant From Benign Ovarian Tumours
Keywords: خطر ابتلا به بدخیمی; Ovarian cancer; serum biomarker; risk of malignancy index; CA 125; HE 4; ROC curve; AUC; area under the curve; FGF-2; fibroblast growth factor 2; HE 4; human epididymis protein 4; IGF-II; insulin-like growth factor II; IL-18; interleukin-18; MIF; macropha
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
Keywords: خطر ابتلا به بدخیمی; HE4; CA125; Ultrasound; Ovarian neoplasm; Risk of malignancy index; Subjective assessment; Risk of ovarian malignancy algorithm; Sensitivity and specificity;
External validation of the adapted Risk of Malignancy Index incorporating tumor size in the preoperative evaluation of adnexal masses
Keywords: خطر ابتلا به بدخیمی; Adnexal masses; Preoperative evaluation; Risk of Malignancy Index; Ultrasound;
Should we centralise care for the patient suspected of having ovarian malignancy?
Keywords: خطر ابتلا به بدخیمی; Ovarian cancer; Centralised care; Cost effective analysis; Gynecologic oncologist; Risk of malignancy index
Evaluation of the risk of malignancy index in daily clinical management of adnexal masses
Keywords: خطر ابتلا به بدخیمی; Adnexal masses; Preoperative evaluation; Risk of malignancy index; Ultrasound
Comparison of four malignancy risk indices in the preoperative evaluation of patients with pelvic masses
Keywords: خطر ابتلا به بدخیمی; Pelvic mass; Risk of malignancy index; Ovarian cancer; Ultrasound
Distinguishing benign and malignant pelvic masses: The value of different diagnostic methods in everyday clinical practice
Keywords: خطر ابتلا به بدخیمی; Pelvic mass; MRI; Diagnostic work-up; Risk of malignancy index
The risk of malignancy index in discrimination of adnexal masses
Keywords: خطر ابتلا به بدخیمی; Ovarian cancer;; Risk of malignancy index;; Serum CA125 level;; Ultrasound score;; Menopausal state